• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Enforcement Report - Week of September 4, 2013

  • Print
  • Share
  • E-mail
-

Product Detail

Product Description Source Plasma
Recall Number B-2200-13
Classification Class III
Code Info 6240116008, 6240114828, 6240114488, 6240113180, 6240112683, 6240112255, 6240111762, 6240111293, 6240104434, 6240103955, 6240103468, 6240102459, 6240102151, 6240101060, 6240100545, 6240100249, 6240096498, 6240096282, 6240095705, 6240095542, 6240094616, 6240094335, 6240171459, 6240170301, 6240169568, 6240168524, 6240167858, 6240159565, 6240157733, 6240242264, 6240235823, 6240235001, 6240233210, 6240232410, 6240230671, 6240229798, 6240227180, 6240226607, 6240224825, 6240224324, 6240222569, 6240221010, 6240219932, 6240218272, 6240217915, 6240215921, 6240215367, 6240212924, 6240211102, 6240210399, 6240208844, 6240208360, 6240206665, 6240205717, 6240204263, 6240203661, 6240202068, 6240201476
Product Distributed Qty 58 units
Reason For Recall Blood products, collected from a donor who was deferred for specific high risk behavior, were distributed.

Event Detail

Event Id 54968
Product Type Biologics
Status Terminated
Recalling Firm CSL Plasma, Inc.
City Tucson
State AZ
Country US
Voluntary / Mandated Voluntary: Firm Initiated
Recall Initiation Date 2010-10-02
Initial Firm Notification of Consignee or Public Other
Distribution Pattern Illinois.
-
-